Biochemical Assays, Pharmacokinetics and Presentation

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Biochemical Assays

Pharmacokinetics

Presentation

Biochemical assays and deep cyclic inhibition in cancer treatment

Drug Target Review

JULY 12, 2023

Molecular-level biochemical assays like transcriptomics, genomics and proteomics have emerged as valuable tools for identifying potential targets in cancer treatment through deep cyclic inhibition (DCI). We are pleased that to date our lead product candidate has aligned DCI profiles as expected.

Biochemical Assays

Biochemical Assays Treatment Bioinformatics Disease

SARS-CoV-2 main protease. Crowdsourcing, peptidomimetics and fragments

Molecular Design

JULY 18, 2020

I’ve been looking at the published inhibitors shown below in Chart 1 (which exhibit antiviral activity and have been subjected to pharmacokinetic and toxicological evaluation) and have written some notes on mapping the structure-activity relationship for compounds like these.

Biochemical Assays

Biochemical Assays Fragment Screening Pharmacokinetics Drugs

Drug Discovery Digest

Biochemical assays and deep cyclic inhibition in cancer treatment

SARS-CoV-2 main protease. Crowdsourcing, peptidomimetics and fragments

Stay Connected